Immunotherapy as a means to induce transplantation tolerance (Q34786983)

4 August 2017

1 reference

title

Immunotherapy as a means to induce transplantation tolerance (English)

1 reference

4 August 2017

1 reference

Scott H Adler

1

1 reference

PubMed ID

12183169

4 August 2017

Laurence A Turka

series ordinal

2

1 reference

4 August 2017

1 October 2002

1 reference

Current Opinion in Immunology

4 August 2017

1 reference

4 August 2017

14

1 reference

4 August 2017

5

1 reference

4 August 2017

660-665

1 reference

Strategies for making more organs available for transplantation

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

1 reference

7 January 2021

Mixed chimerism and transplant tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Tolerance to solid organ transplants through transfer of MHC class II genes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Treatment with immunotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

CAMPATH-1H in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Campath-1H monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

The role of CD154 in organ transplant rejection and acceptance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

How do monoclonal antibodies induce tolerance? A role for infectious tolerance?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Regulatory T cells overexpress a subset of Th2 gene transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Donor-derived IP-10 initiates development of acute allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

IL-15 and IL-2: a matter of life and death for T cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900376-X

7 January 2021

10.1016/S0952-7915(02)00376-X

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12183169